Anne Caron

A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Vincent Ribrag, Jehan Dupuis, Hervé Tilly et al. · Clinical Cancer Research · 2013 · 104 citations

Pharmacy, Oncology, Pharmacology +17

Discovery of (2<i>S</i>)-8-[(3<i>R</i>)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2<i>H</i>-pyrimido[1,2-<i>a</i>]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Benoit Pasquier, Youssef El‐Ahmad, Bruno Filoche-Rommé et al. · Journal of Medicinal Chemistry · 2014 · 92 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Maysoun Shomali, Jane Cheng, Fangxian Sun et al. · Molecular Cancer Therapeutics · 2020 · 67 citations · Full text

Medicine, Oncology, Pharmacology +15

Local Gene Transfer and Expression Following Intramuscular Administration of FGF-1 Plasmid DNA in Patients With Critical Limb Ischemia

Iris Baumgärtner, Nicolas Chronos, Anthony J. Comerota et al. · Molecular Therapy · 2009 · 59 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +16

Effective clearance of GL‐3 in a human iPSC‐derived cardiomyocyte model of Fabry disease

Jean‐Michel Itier, Gwénaëlle Ret, Sandra Viale et al. · Journal of Inherited Metabolic Disease · 2014 · 52 citations

Life Sciences, Molecular Biology, Physiology +6